BTMD
biote Corp.
NASDAQ · Healthcare · Medical - Care Facilities · US
$1.36
+0.74%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.35
From 52W high−59.64%
Volume147427.00
Market cap$39.00M
P/E (TTM)8.1x
P/S (TTM)0.2x
Div yield—
Key dataSep 18, 2026
Open
$1.35
From 52W high
−59.64%
Volume
147427.00
Market cap
$39.00M
ValuationView details →
P/E (Fwd)
9.7x
EV/EBITDA
7.0x
P/E (TTM)
8.1x
RSI (14)
37.4
MomentumView details →
1D Return
+0.74%
YTD Return
−48.08%
SummaryUpdated Jun 1, 2026
Biote Corp. (NASDAQ:BTMD) is a medical practice-building company that operates within the hormone optimization healthcare sector. Founded in 2011 and headquartered in Irving, Texas, the company went public in April 2021. Biote has established itself as a leading provider of bioidentical hormone replacement therapy solutions, serving a network of over 8,600 healthcare providers across the United States. The company operates through a franchise-like model, providing practitioners with training, certification, proprietary software, and products needed to offer hormone optimization treatments to patients.
Similar companies
Latest newsMore news →
biote reported lower second-quarter revenue and a net loss for the quarter ended June 2026, with results impacted by a voluntary recall of hormone pellets supplied by Asteria Health that disrupted procedure volumes.46d agoMarc Beer was appointed Executive Chairman of the Board of biote Corp., effective June 8, 2026.111d agoRobert Peterson was appointed Interim Chief Executive Officer and Director of biote Corp., effective June 8, 2026.111d ago